FDA.reportPublic FDA data

Orladeyo 110 MG Oral Capsule

RxCUI
2467575
RxNorm name
Orladeyo 110 MG Oral Capsule
Display name
Orladeyo 110 MG Oral Capsule
Full name
Orladeyo 110 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3527ece1-e7e0-40b1-b0c5-6baeb0deabeborladeyo 110 MG Oral Capsule [PSN] · berotralstat 110 MG Oral Capsule [Orladeyo] [SBD] · Orladeyo 110 MG Oral Capsule [SY]38These highlights do not include all the information needed to use ORLADEYO ® safely and effectively. See full prescribing information for ORLADEYO. ORLADEYO (berotralstat) capsules, for oral use ORLADEYO (berotralstat) oral pellets Initial U.S. Approval: 202020260213